// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























3340 Abstracts

PREDICTORS OF MITRAL REGURGITATION PROGRESSION IN PATIENTS WITH ADVANCED ISCHEMIC CARDIOMYOPATHY: A MULTI-MODALITY STUDY

Kenya Kusunose - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

EXTRACELLULAR MATRIX EXPANSION IN NON-INFARCTED MYOCARDIUM IS ASSOCIATED WITH SUBSEQUENT DEATH, HOSPITALIZATION FOR HEART FAILURE, OR BOTH ACROSS THE EJECTION FRACTION SPECTRUM

Erik B. Schelbert - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Heart muscle disease

Methadone hydrochloride

IMPAIRED HYPEREMIC MYOCARDIAL BLOOD FLOW IS ASSOCIATED WITH INDUCIBILITY OF VENTRICULAR ARRHYTHMIA IN ISCHEMIC CARDIOMYOPATHY

Mischa Rijnierse - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

PROGNOSTIC SIGNIFICANCE OF CARDIOVASCULAR MAGNETIC RESONANCE FEATURE TRACKING DERIVED CIRCUMFERENTIAL STRAIN IN CHILDREN UNDERGOING FAMILY SCREENING AND PAEDIATRIC PATIENTS WITH SUSPECTED CARDIOMYOPATHY

Joanna Petryka - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

THE PROGNOSTIC UTILITY OF MYOCARDIAL FIBROSIS IN PEDIATRIC CARDIOMYOPATHY SERVICE

Joanna Petryka - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

ASSOCIATION OF AORTIC STIFFNESS WITH BIOMARKERS OF MYOCARDIAL WALL STRESS AFTER MYOCARDIAL INFARCTION

Gert Klug - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Adrenomedullin

SUCCESSFUL RISK STRATIFICATION USING A COMBINATION OF LV FIBROSIS AND NUMBER OF MORPHOLOGICAL TYPES OF VENTRICULAR PREMATURE BEATS IN SUBJECTS WITH NON-ISCHEMIC CARDIOMYOPATHY

Nobusada Funabashi - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

INCREASING ALCOHOL CONSUMPTION IS RELATED TO DETRIMENTAL CHANGES IN CARDIAC STRUCTURE AND FUNCTION

Alexandra Goncalves - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Heart muscle disease

N/A

ILLICIT DRUG USE AND DIASTOLIC FUNCTION: DATA FROM THE MIND YOUR HEART STUDY

Payal Kohli - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Amphetamine Aspartate

NOT MYOCARDIAL PERFUSION STATUS ITSELF, BUT ITS FINAL HEMODYNAMIC CONSEQUENCE IS RELATED TO MYOCARDIAL SYSTOLIC FUNCTION IN HYPERTROPHIC CARDIOMYOPATHY: INTEGRATED APPROACH WITH ECHOCARDIOGRAPHY AND CARDIAC MAGNETIC RESONANCE IMAGING

Sahmin Lee - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Adenosine

LEFT BUNDLE BRANCH BLOCK INFLUENCES CORONARY FLOW RESERVE IN NON-ISCHEMIC DILATED CARDIOMYOPATHY

Quirino Ciampi - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

dipyridamole

UTILITY OF IODINE-123-METAIODOBENZYLGUANIDINE IMAGING IN PREDICTING CLINICALLY RELEVANT VENTRICULAR ARRHYTHMIAS IN PATIENTS WITH SYSTOLIC HEART FAILURE: A SYSTEMATIC REVIEW

Janardhana R. Gorthi - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

I-123

ABNORMAL GLOBAL LONGITUDINAL STRAIN TO PREDICT OUTCOMES IN HYPERTROPHIC CARDIOMYOPATHY

Patrick Timothy Strickland - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

CAN WE MEASURE WITH STRAIN IMAGING THE AMOUNT OF CARDIAC FIBROSIS IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY?

Kevin Kumar Manocha - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

IMPROVEMENT OF ECHOCARDIOGRAPHIC CIRCUMFERENTIAL MECHANICAL DISPERSION BY CARDIAC RESYNCHRONIZATION THERAPY IS RELATED TO LESS VENTRICULAR ARRHYTHMIAS

Nina E. Hasselberg - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

PROGNOSTIC VALUE OF BASELINE CARDIOVASCULAR MAGNETIC RESONANCE IMAGING MEASURES OF LEFT VENTRICULAR GEOMETRY AND FUNCTION IN 366 PATIENTS UNDERGOING SURGERY FOR ISCHEMIC CARDIOMYOPATHY: RESULTS FROM NIH SPONSORED STICH TRIAL

Ramdas G. Pai - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

N/A

NOVEL INSIGHTS INTO THE MECHANISM OF RIGHT VENTRICULAR MEASURES IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY

Marwa Sabe - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

OPTIMAL PERI-INFARCT AND CORE INFARCT THRESHOLDS FOR THE ASSESSMENT OF MORTALITY RISK IN PATIENTS WITH SEVERE ISCHEMIC CARDIOMYOPATHY

Monique Robinson - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

RELATIONSHIP BETWEEN MITRAL REGURGITATION AND LEFT VENTRICULAR REMODELING: IMPORTANCE OF 3D ECHOCARDIOGRAPHIC ASSESSMENT OF VENTRICULAR SHAPE IN DILATED CARDIOMYOPATHY

Francesco Maffessanti - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Mofezolac

ECHOCARDIOGRAPHIC FINDINGS IN TAKOTSUBO CARDIOMYOPATHY: BEYOND APICAL BALLOONING

Nobuyuki Kagiyama - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Copyright © 2026. QuantiNova All rights reserved